Literature DB >> 11223545

Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum.

S Yamada1, Y Ajioka, H Watanabe, H Hashidate, H Takaku, S Kazama, J Yokoyama, K Nishikura, T Fujiwara, H Asakura.   

Abstract

The aim of this study was to elucidate whether or not p53 genetic heterogeneity would occur while colorectal carcinoma was limited to the mucosa. Eight cases of endoscopically resected colorectal intramucosal carcinomas were analyzed to determine the p53 gene sequence (exons 5 to 8). Six out of 8 cases showed p53 gene mutations, and in all of them, the mutational status was heterogeneous. In 4 cases, mutated codons were heterogeneous as well. These data indicate that p53 gene alterations in colorectal carcinomas occur and diverge at the stage of intramucosal carcinoma, supporting our previously proposed hypothesis that colorectal carcinomas can be composed of various subclones as regards p53 gene mutation, while the carcinoma is limited to the mucosa, and one of these subclones commences invasion to the submucosa after clonal selection, thus generating a monoclonal invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223545      PMCID: PMC5926696          DOI: 10.1111/j.1349-7006.2001.tb01078.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

1.  Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections.

Authors:  C A Moskaluk; S E Kern
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Microsatellite instability in young patients with colorectal cancer.

Authors:  W H Kim; H W Lee; S H Park; Y I Kim; J G Chi
Journal:  Pathol Int       Date:  1998-08       Impact factor: 2.534

3.  Genetic heterogeneity in sporadic colorectal adenomas.

Authors:  E Saraga; D Bautista; G Dorta; P Chaubert; P Martin; B Sordat; P Protiva; A Blum; F Bosman; J Benhattar
Journal:  J Pathol       Date:  1997-03       Impact factor: 7.996

4.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder.

Authors:  Y Oohashi; H Watanabe; Y Ajioka; K Hatakeyama
Journal:  Pathol Int       Date:  1995-01       Impact factor: 2.534

7.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

8.  Somatic mutations detected by mini- and microsatellite DNA markers reveal clonal intratumor heterogeneity in gastrointestinal cancers.

Authors:  S Nagel; B Borisch; S L Thein; M Oestreicher; F Nöthiger; S Birrer; A Tobler; M F Fey
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

9.  Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.

Authors:  B R Dix; P D Robbins; D V Spagnolo; G L Padovan; A K House; B J Iacopetta
Journal:  Diagn Mol Pathol       Date:  1995-12

10.  A frequent alteration of p53 gene in carcinoma in adenoma of colon.

Authors:  M Ohue; N Tomita; T Monden; M Fujita; M Fukunaga; K Takami; I Yana; T Ohnishi; T Enomoto; M Inoue
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

View more
  1 in total

1.  Endoscopic resection of superficial gastrointestinal tumors.

Authors:  Giovannini Marc; Cesar Vivian Lopes
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.